# OnCo record paper-patricia-paavonen-lancet-2009 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-patricia-paavonen-lancet-2009/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-patricia-paavonen-lancet-2009" ;
  schema:name "Efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis"@en ;
  schema:description "In young women free of the two target virus types at vaccination, the bivalent vaccine prevented 93 percent of high-grade cervical precancers caused by those types, and it also protected against some related virus types it was not designed for."@en ;
  schema:url <https://onco.cc/key-papers/paper-patricia-paavonen-lancet-2009/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(09)61248-4>, <https://pubmed.ncbi.nlm.nih.gov/19586656/>, <https://clinicaltrials.gov/study/NCT00122681> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(09)61248-4> ;
  schema:datePublished "2009"^^xsd:gYear ;
  schema:author "Paavonen J, Naud P, Salmerón J, et al." ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/hpv-bivalent-vaccine/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:trials <https://onco.cc/trials/patricia/> ;
  onco:journals <https://onco.cc/journals/lancet/> .